PrognomiQ
San Mateo
About PrognomiQ
PrognomiQ is a technology company that focuses on transforming early disease detection and treatment through multi-omics data. The company generates extensive proteomic, genomic, and metabolomic data to provide insights into complex diseases, aiming to improve patient outcomes. PrognomiQ's innovative approach facilitates the development of advanced test products that enhance the understanding and management of health conditions.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $147.2M
- Last round: Series Unknown (Jan 2026)
- Website: prognomiq.com
- Phone: 650 750-2447
Industries & Categories
Biopharma, Biotechnology, Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/prognomiq-123141 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.